Literature DB >> 16216409

Overexpression of PML induced apoptosis in bladder cancer cell by caspase dependent pathway.

Lei Li1, Dalin He, Hui He, Xinyang Wang, Linlin Zhang, Yong Luo, Xunyi Nan.   

Abstract

The promyelocytic leukemia gene (PML) encodes a growth/tumor suppressor protein that is essential for the induction of apoptosis in response to various apoptotic signals. The mechanism by which PML plays a role in the regulation of cell death is still unknown. Our previous study demonstrated that overexpression of PML suppress the growth of bladder cancer cells by inducing apoptosis and cell cycle arrest. To further elucidate the mechanism of PML induced apoptosis in bladder cancer, we constructed a PML inducible stable cell line. We found that the increased expression of PML significantly inhibit the growth of the UM-UC-2/PML clone cells and present apparent massive apoptosis in 24 h post-induction, while the UM-UC-2/PMEP4 cells are not. We also examined the effect of PML on the cell cycle distribution in UM-UC-2 cells. We showed overexpression of PML cause a cell cycle arrest in G1 phase. In additional, increased expression of PML in bladder cancer UM-UC-2 cells reduce Survivin expression and up regulated Caspase-3, and cleaved PARP expression, these suggested that PML might regulate apoptosis through Caspase dependent pathways. Our results demonstrate a novel mechanism of PML-induced apoptosis by down-regulation of Survivin and activation of Caspase dependent pathway.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16216409     DOI: 10.1016/j.canlet.2005.05.034

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  6 in total

1.  PML: An emerging tumor suppressor and a target with therapeutic potential.

Authors:  Erin L Reineke; Hung-Ying Kao
Journal:  Cancer Ther       Date:  2009-09-01

2.  PrLZ protects prostate cancer cells from apoptosis induced by androgen deprivation via the activation of Stat3/Bcl-2 pathway.

Authors:  Dong Zhang; Dalin He; Yan Xue; Ruoxiang Wang; Kaijie Wu; Hongjun Xie; Jin Zeng; Xinyang Wang; Haiyen E Zhau; Leland W K Chung; Luke S Chang; Lei Li
Journal:  Cancer Res       Date:  2011-03-08       Impact factor: 12.701

3.  Promyelocytic leukemia protein induces apoptosis due to caspase-8 activation via the repression of NFkappaB activation in glioblastoma.

Authors:  Kazuyuki Kuwayama; Kazuhito Matsuzaki; Yoshihumi Mizobuchi; Hideo Mure; Keiko T Kitazato; Teruyoshi Kageji; Mitsuyoshi Nakao; Shinji Nagahiro
Journal:  Neuro Oncol       Date:  2008-09-23       Impact factor: 12.300

4.  The human promyelocytic leukemia protein is a tumor suppressor for murine skin carcinogenesis.

Authors:  Victoria M Virador; Rafael E Flores-Obando; Adam Berry; Rinal Patel; Julia Zakhari; Yu-Chien Lo; Kathryn Strain; Joanna Anders; Christophe Cataisson; Laura A Hansen; Stuart H Yuspa
Journal:  Mol Carcinog       Date:  2009-07       Impact factor: 4.784

5.  Twisted epithelial-to-mesenchymal transition promotes progression of surviving bladder cancer T24 cells with hTERT-dysfunction.

Authors:  Yan Xue; Lei Li; Dong Zhang; Kaijie Wu; Yule Chen; Jin Zeng; Xinyang Wang; Dalin He
Journal:  PLoS One       Date:  2011-11-15       Impact factor: 3.240

6.  Cardiac Glycosides Activate the Tumor Suppressor and Viral Restriction Factor Promyelocytic Leukemia Protein (PML).

Authors:  Snezana Milutinovic; Susanne Heynen-Genel; Elizabeth Chao; Antimone Dewing; Ricardo Solano; Loribelle Milan; Nikki Barron; Min He; Paul W Diaz; Shu-ichi Matsuzawa; John C Reed; Christian A Hassig
Journal:  PLoS One       Date:  2016-03-31       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.